Cargando…
Comparing Tumor Cell Invasion and Myeloid Cell Composition in Compatible Primary and Relapsing Glioblastoma
SIMPLE SUMMARY: We established a new minimally invasive mouse model for GBM relapse. For this, we utilized orthotopical implantation of HSVTK-transduced GBM cells and pharmacological treatment with GCV. In addition, we implanted patient-derived GBM cells of primary or recurrent tumors. We found that...
Autores principales: | Zhao, Dongxu, Zhang, Huabin, Uyar, Ramazan, Hossain, Jubayer A., Miletic, Hrvoje, Tonn, Jörg-Christian, Glass, Rainer, Kälin, Roland E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303884/ https://www.ncbi.nlm.nih.gov/pubmed/34298846 http://dx.doi.org/10.3390/cancers13143636 |
Ejemplares similares
-
Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells
por: Cai, Linzhi, et al.
Publicado: (2020) -
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
por: Andersen, Johannes K., et al.
Publicado: (2022) -
APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma
por: Kälin, Roland E., et al.
Publicado: (2021) -
Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects
por: Hossain, Jubayer A, et al.
Publicado: (2020) -
OMRT-1. Cannabidiol converts NFKB into a tumor-suppressor in glioblastoma with defined antioxidative properties
por: Volmar, Marie, et al.
Publicado: (2021)